Wells Fargo’s Fennec Pharmaceuticals FENC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $118K | Buy |
14,259
+598
| +4% | +$4.96K | ﹤0.01% | 4698 |
|
|
2025
Q1 | $83.2K | Buy |
13,661
+509
| +4% | +$3.1K | ﹤0.01% | 4746 |
|
|
2024
Q4 | $83.1K | Buy |
13,152
+3,155
| +32% | +$19.9K | ﹤0.01% | 4806 |
|
|
2024
Q3 | $50K | Buy |
9,997
+302
| +3% | +$1.51K | ﹤0.01% | 4943 |
|
|
2024
Q2 | $59.2K | Buy |
9,695
+3,676
| +61% | +$22.5K | ﹤0.01% | 4868 |
|
|
2024
Q1 | $66.9K | Buy |
6,019
+795
| +15% | +$8.84K | ﹤0.01% | 4759 |
|
|
2023
Q4 | $58.6K | Buy |
5,224
+1,088
| +26% | +$12.2K | ﹤0.01% | 4794 |
|
|
2023
Q3 | $31.1K | Sell |
4,136
-2,814
| -40% | -$21.1K | ﹤0.01% | 5058 |
|
|
2023
Q2 | $61.4K | Buy |
6,950
+6,644
| +2,171% | +$58.7K | ﹤0.01% | 5051 |
|
|
2023
Q1 | $2.55K | Buy |
+306
| New | +$2.55K | ﹤0.01% | 5867 |
|
|
2021
Q4 | – | Sell |
-1,400
| Closed | -$13K | – | 6807 |
|
|
2021
Q3 | $13K | Hold |
1,400
| – | – | ﹤0.01% | 5785 |
|
|
2021
Q2 | $10K | Sell |
1,400
-184,509
| -99% | -$1.32M | ﹤0.01% | 5804 |
|
|
2021
Q1 | $1.16M | Buy |
185,909
+130,941
| +238% | +$813K | ﹤0.01% | 3896 |
|
|
2020
Q4 | $409K | Buy |
54,968
+4,122
| +8% | +$30.7K | ﹤0.01% | 4571 |
|
|
2020
Q3 | $308K | Buy |
50,846
+38,097
| +299% | +$231K | ﹤0.01% | 4554 |
|
|
2020
Q2 | $106K | Buy |
12,749
+10,949
| +608% | +$91K | ﹤0.01% | 4990 |
|
|
2020
Q1 | $11K | Buy |
+1,800
| New | +$11K | ﹤0.01% | 5445 |
|
|
2019
Q3 | – | Sell |
-1,074
| Closed | -$4K | – | 5966 |
|
|
2019
Q2 | $4K | Sell |
1,074
-14,334
| -93% | -$53.4K | ﹤0.01% | 5644 |
|
|
2019
Q1 | $75K | Sell |
15,408
-17
| -0.1% | -$83 | ﹤0.01% | 5127 |
|
|
2018
Q4 | $98K | Buy |
15,425
+13,641
| +765% | +$86.7K | ﹤0.01% | 5050 |
|
|
2018
Q3 | $14K | Buy |
1,784
+396
| +29% | +$3.11K | ﹤0.01% | 5541 |
|
|
2018
Q2 | $14K | Buy |
+1,388
| New | +$14K | ﹤0.01% | 5551 |
|